{"data":[{"accessionNo":"0002100119-26-000245","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001048477","issuerName":"BioMarin Pharmaceutical Inc","ticker":"BMRN","cusip":"09061G101","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":10113219,"percentOfClass":5.25,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000102909-26-000752","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001048477","issuerName":"BioMarin Pharmaceutical Inc","ticker":"BMRN","cusip":"09061G101","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0002012383-26-000650","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":17560751,"percentOfClass":9.1,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":8322179,"percentOfClass":4.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":8322179,"percentOfClass":4.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":8322179,"percentOfClass":4.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Ott David C.","reportingCik":null,"personType":"IN","sharesOwned":8322179,"percentOfClass":4.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Equities Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":5289066,"percentOfClass":2.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"VIKING GLOBAL PERFORMANCE LLC","reportingCik":null,"personType":"OO","sharesOwned":5397003,"percentOfClass":2.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Long Fund GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2094037,"percentOfClass":1.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Long Fund Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2094037,"percentOfClass":1.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":831139,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Liquid Portfolio Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":831139,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":831139,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":831139,"percentOfClass":0.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"},{"accessionNo":"0000905148-25-004061","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001048477","issuerName":"BIOMARIN PHARMACEUTICAL INC","ticker":"BMRN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Equities II LP","reportingCik":null,"personType":"PN","sharesOwned":107937,"percentOfClass":0.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn"}],"updatedAt":"2026-10-29T08:30:08.687Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bmrn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}